2402 Sorafenib (SOR) dose reduction attenuates its immunosuppressive effects and delays hepatocellular cancer (HCC) development in the woodchuck model of hepatitis B related HCC
Iyer, R, Patel, P, Buitrago, S, Curtin, L, Fetterly, G, Maguire, O, Minderman, H, Toshkov, I, Tennant, B, Hutson, A, Johnson, C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors
U Vanhoefer, S Cao, H Minderman, K Toth, B S Skenderis, 2nd, M L Slovak, Y M Rustum
Published in Clinical cancer research (01.12.1996)
Get full text
Published in Clinical cancer research (01.12.1996)
Journal Article
Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis
Voigt, W, Matsui, S, Yin, M B, Burhans, W C, Minderman, H, Rustum, Y M
Published in Anticancer research (01.09.1998)
Get more information
Published in Anticancer research (01.09.1998)
Journal Article
1195P - Safety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101
Babiker, H., Borazanci, E., Subbiah, V., Maguire, O., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Bindra, G., Iverson, I., Chunduru, S., Anderson, P., Puzanov, I., Diab, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1195PSafety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101
Babiker, H, Borazanci, E, Subbiah, V, Maguire, O, Rahimian, S, Minderman, H, Haymaker, C, Bernatchez, C, Bindra, G, Iverson, I, Chunduru, S, Anderson, P, Puzanov, I, Diab, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Safety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101
Babiker, H., Borazanci, E., Subbiah, V., Maguire, O., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Bindra, G., Iverson, I., Chunduru, S., Anderson, P., Puzanov, I., Diab, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein
VANHOEFER, U, SHOUSONG CAO, MINDERMAN, H, TOTH, K, SCHEPER, R. J, SLOVAK, M. L, RUSTUM, Y. M
Published in Clinical cancer research (01.02.1996)
Get full text
Published in Clinical cancer research (01.02.1996)
Journal Article
1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
Babiker, H., Borazanci, E., Subbiah, V., Algazi, A.P., Schachter, J., Lotem, M., Hendler, D., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Murthy, R., Hultsch, R., Caplan, N., Woodhead, G.J., Hennemeyer, C.T., Chunduru, S., Anderson, P., Diab, A., Puzanov, I.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Response to letter from Dr Domenico Ribatti
Bunworasate, U, Arnouk, H, Minderman, H, O'Loughlin, K.L, Sait, S.N.J, Barcos, M, Stewart, C.C, Baer, M.R
Published in Leukemia (01.09.2002)
Published in Leukemia (01.09.2002)
Get full text
Journal Article
P-156 A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer
Fountzilas, C., Mukherjee, S., Saltzman, J., Bajor, D., Muhitch, J., Abrams, S., Maguire, O., Minderman, H., Wang, K., Hutson, A., Hicks, K., Ventola, J., Kalinski, P., Iyer, R., Boland, P.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
Idarubicin DNA intercalation is reduced by MRP1 and not Pgp
SMEETS, M. E. P, RAYMAKERS, R. A. P, VIERWINDEN, G, PENNINGS, A. H. M, BOEZEMAN, J, MINDERMAN, H, DE WITTE, T. M
Published in Leukemia (01.09.1999)
Published in Leukemia (01.09.1999)
Get full text
Journal Article
Neem oil limonoids induces p53-independent apoptosis and autophagy
SRIVASTAVA, Pragya, YADAV, Neelu, CHANDRA, Dhyan, LELLA, Ravi, SCHNEIDER, Andrea, JONES, Anthony, MARLOWE, Timothy, LOVETT, Gabrielle, O'LOUGHLIN, Kieran, MINDERMAN, Hans, GOGADA, Raghu
Published in Carcinogenesis (New York) (01.11.2012)
Published in Carcinogenesis (New York) (01.11.2012)
Get full text
Journal Article
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, Misbah, O'Loughlin, Kieran L, Fricke, Stacy M, Williamson, Nicole A, Greco, William R, Minderman, Hans, Baer, Maria R
Published in Clinical cancer research (15.03.2005)
Published in Clinical cancer research (15.03.2005)
Get full text
Journal Article
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein
MINDERMAN, Hans, O'LOUGHLIN, Kieran L, PENDYALA, Lakshmi, BAER, Maria R
Published in Clinical cancer research (01.03.2004)
Published in Clinical cancer research (01.03.2004)
Get full text
Journal Article
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720
Baer, Maria R., George, Stephen L., Dodge, Richard K., O'Loughlin, Kieran L., Minderman, Hans, Caligiuri, Michael A., Anastasi, John, Powell, Bayard L., Kolitz, Jonathan E., Schiffer, Charles A., Bloomfield, Clara D., Larson, Richard A.
Published in Blood (15.08.2002)
Published in Blood (15.08.2002)
Get full text
Journal Article
Evaluation of topoisomerase I catalytic activity as determinant of drug response in human cancer cell lines
Voigt, W, Vanhoefer, U, Yin, M B, Minderman, H, Schmoll, H J, Rustum, Y M
Published in Anticancer research (01.09.1997)
Get more information
Published in Anticancer research (01.09.1997)
Journal Article